1.
Nat Biotechnol
; 24(6): 653-5, 2006 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16763591
RESUMO
Applicants in Europe are left with few options for the patent protection of hES cell-related technology.